Manufacturing Analytics controls prefilled injectable dosage
A pharmaceutical industry trend is the migration from vials to prefilled syringes especially for biologics. Since this is the final administered dose, fill control requirements are rigorous and leading pharmaceutical producers rely heavily on manufacturing analytics (MA) for control.
Risk reduction, cost control and more accurate drug delivery drive the migration from vials to prefilled injectables: